Coronary artery bypass grafting in Native Americans: a higher risk of death compared to other ethnic groups?

B K Nallamothu1, S Saint, S Saha

  • 1Department of Internal Medicine, University of Michigan Medical School, Ann Arbor 48109-0022, USA. bnallamo@umich.edu

Insights

Coronary artery bypass grafting (CABG) may pose a higher in-hospital death risk for Native Americans compared to other ethnic groups. Further research is needed to confirm these findings in this population.

Area of Science:

  • Cardiovascular Surgery
  • Health Disparities
  • Ethnic Health Outcomes

Background:

  • Coronary artery bypass grafting (CABG) is a well-established procedure.
  • Limited data exists on CABG outcomes specifically for Native Americans.

Purpose of the Study:

  • To investigate ethnic differences in clinical outcomes following CABG.
  • To assess in-hospital mortality and length of stay among Native Americans undergoing CABG.

Main Methods:

  • Analysis of a national database including 18,061 patients from 25 U.S. healthcare facilities.
  • Classification of patients into five ethnic groups: Native American, white, African American, Hispanic, and Asian.
  • Statistical adjustment for age, gender, surgical priority, case-mix severity, insurance, and facility characteristics.

Main Results:

  • Native Americans exhibited a significantly higher adjusted risk for in-hospital death compared to white, African American, Hispanic, and Asian patients.
  • Odds ratios for in-hospital death ranged from 2.8 to 7.1 across comparisons with other ethnic groups.
  • No significant ethnic differences were observed in the length of stay post-CABG.

Conclusions:

  • The risk of in-hospital mortality after CABG may be elevated in Native Americans.
  • Further research with larger sample sizes is necessary to validate these findings due to the limited number of Native American patients in the study.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...